{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "https://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Thangam+Debbonaire&AnswerDate=2016-11-04&AnsweringBody.=Department+for+Business%2C+Energy+and+Industrial+Strategy", "definition" : "https://eldaddp.azurewebsites.net/meta/answeredquestions.text?tablingMemberPrinted.=Thangam+Debbonaire&AnswerDate=2016-11-04&AnsweringBody.=Department+for+Business%2C+Energy+and+Industrial+Strategy", "extendedMetadataVersion" : "https://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Thangam+Debbonaire&AnswerDate=2016-11-04&AnsweringBody.=Department+for+Business%2C+Energy+and+Industrial+Strategy&_metadata=all", "first" : "https://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Thangam+Debbonaire&_page=0&AnswerDate=2016-11-04&AnsweringBody.=Department+for+Business%2C+Energy+and+Industrial+Strategy", "hasPart" : "https://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Thangam+Debbonaire&AnswerDate=2016-11-04&AnsweringBody.=Department+for+Business%2C+Energy+and+Industrial+Strategy", "isPartOf" : "https://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Thangam+Debbonaire&AnswerDate=2016-11-04&AnsweringBody.=Department+for+Business%2C+Energy+and+Industrial+Strategy", "items" : [{"_about" : "http://data.parliament.uk/resources/626753", "AnsweringBody" : [{"_value" : "Department for Business, Energy and Industrial Strategy"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/626753/answer", "answerText" : {"_value" : "
The UK Patents Act 1977, in line with the WTO TRIPS Agreement, provides for compulsory licenses in certain circumstances.<\/p>
<\/p>
Kadcyla (trastuzumab emtansine) is currently available to patients in England for the treatment of HER2-positive locally advanced, unresectable or metastatic breast cancer through the Cancer Drugs Fund.<\/p>
<\/p>
The National Institute for Health and Care Excellence (NICE) is currently reviewing its technology appraisal guidance on trastuzumab emtansine for refractory, HER2 positive breast cancer. NICE expects to publish its updated guidance in February 2017.<\/p>
<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4039", "label" : {"_value" : "Biography information for Lord Johnson of Marylebone"} } , "answeringMemberConstituency" : {"_value" : "Orpington"} , "answeringMemberPrinted" : {"_value" : "Joseph Johnson"} , "dateOfAnswer" : {"_value" : "2016-11-04", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2016-11-04T14:03:54.493Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "201"} , "answeringDeptShortName" : {"_value" : "Business, Energy and Industrial Strategy"} , "answeringDeptSortName" : {"_value" : "Business, Energy and Industrial Strategy"} , "date" : {"_value" : "2016-11-01", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Intellectual Property: Drugs"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Business, Energy and Industrial Strategy, what his Department's policy is on using the flexibility provided by the Trade Related Aspects of Intellectual Property Rights under World Trade Organisation rules for compulsory license for the Kadcyla form of trastuzumab emtansine for UK patients.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4433", "label" : {"_value" : "Biography information for Thangam Debbonaire"} } , "tablingMemberConstituency" : {"_value" : "Bristol West"} , "tablingMemberPrinted" : [{"_value" : "Thangam Debbonaire"} ], "uin" : "51439"} ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 1, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} }